[
    [
        {
            "time": "",
            "original_text": "[领先大市-B评级]医药行业周度报告：“互联网+医疗健康”获肯定 抗癌药零关税成定局",
            "features": {
                "keywords": [
                    "互联网+医疗健康",
                    "抗癌药",
                    "零关税"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[领先大市-B评级]医药行业周度报告：“互联网+医疗健康”获肯定 抗癌药零关税成定局",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]医药生物行业投资策略：进口抗癌药关税政策无需过度放大 依然看好国内创新药企业",
            "features": {
                "keywords": [
                    "抗癌药",
                    "关税政策",
                    "国内创新药企业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]医药生物行业投资策略：进口抗癌药关税政策无需过度放大 依然看好国内创新药企业",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报:“互联网+医疗健康”措施确定,覆盖医疗多方市场",
            "features": {
                "keywords": [
                    "互联网+医疗健康",
                    "措施确定",
                    "医疗多方市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业周报:“互联网+医疗健康”措施确定,覆盖医疗多方市场",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]